Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
278 | 18430 | 37.5 | 67% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
184 | 51606 | BIPOLAR DISORDERS//ELECTROCONVULSIVE THERAPY//JOURNAL OF CLINICAL PSYCHIATRY |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RISPERIDONE | Author keyword | 597 | 49% | 5% | 884 |
2 | CLOZAPINE | Author keyword | 559 | 41% | 6% | 1053 |
3 | OLANZAPINE | Author keyword | 558 | 47% | 5% | 872 |
4 | ANTIPSYCHOTICS | Author keyword | 435 | 36% | 5% | 978 |
5 | SCHIZOPHRENIA | Author keyword | 409 | 11% | 19% | 3569 |
6 | ANTIPSYCHOTIC | Author keyword | 307 | 37% | 4% | 658 |
7 | ARIPIPRAZOLE | Author keyword | 252 | 48% | 2% | 383 |
8 | ATYPICAL ANTIPSYCHOTICS | Author keyword | 249 | 45% | 2% | 411 |
9 | AKATHISIA | Author keyword | 192 | 71% | 1% | 154 |
10 | ZIPRASIDONE | Author keyword | 176 | 58% | 1% | 205 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RISPERIDONE | 597 | 49% | 5% | 884 | Search RISPERIDONE | Search RISPERIDONE |
2 | CLOZAPINE | 559 | 41% | 6% | 1053 | Search CLOZAPINE | Search CLOZAPINE |
3 | OLANZAPINE | 558 | 47% | 5% | 872 | Search OLANZAPINE | Search OLANZAPINE |
4 | ANTIPSYCHOTICS | 435 | 36% | 5% | 978 | Search ANTIPSYCHOTICS | Search ANTIPSYCHOTICS |
5 | SCHIZOPHRENIA | 409 | 11% | 19% | 3569 | Search SCHIZOPHRENIA | Search SCHIZOPHRENIA |
6 | ANTIPSYCHOTIC | 307 | 37% | 4% | 658 | Search ANTIPSYCHOTIC | Search ANTIPSYCHOTIC |
7 | ARIPIPRAZOLE | 252 | 48% | 2% | 383 | Search ARIPIPRAZOLE | Search ARIPIPRAZOLE |
8 | ATYPICAL ANTIPSYCHOTICS | 249 | 45% | 2% | 411 | Search ATYPICAL+ANTIPSYCHOTICS | Search ATYPICAL+ANTIPSYCHOTICS |
9 | AKATHISIA | 192 | 71% | 1% | 154 | Search AKATHISIA | Search AKATHISIA |
10 | ZIPRASIDONE | 176 | 58% | 1% | 205 | Search ZIPRASIDONE | Search ZIPRASIDONE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATYPICAL ANTIPSYCHOTICS | 1053 | 50% | 8% | 1502 |
2 | RISPERIDONE | 982 | 44% | 9% | 1692 |
3 | OLANZAPINE | 772 | 44% | 7% | 1336 |
4 | HALOPERIDOL | 711 | 34% | 9% | 1704 |
5 | SCHIZOAFFECTIVE DISORDER | 573 | 45% | 5% | 959 |
6 | 2ND GENERATION ANTIPSYCHOTICS | 526 | 71% | 2% | 421 |
7 | INDUCED WEIGHT GAIN | 525 | 63% | 3% | 528 |
8 | CLOZAPINE | 511 | 32% | 7% | 1324 |
9 | ANTIPSYCHOTICS | 288 | 37% | 3% | 614 |
10 | TARDIVE DYSKINESIA | 253 | 30% | 4% | 704 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL PSYCHIATRY | 149 | 14% | 5% | 964 |
2 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 130 | 21% | 3% | 544 |
3 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 72 | 19% | 2% | 338 |
4 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 70 | 23% | 1% | 262 |
5 | PHARMACOPSYCHIATRY | 43 | 14% | 2% | 280 |
6 | PSYCHOPHARMAKOTHERAPIE | 33 | 24% | 1% | 120 |
7 | PSYCHOPHARMACOLOGY BULLETIN | 32 | 13% | 1% | 230 |
8 | INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 28 | 18% | 1% | 139 |
9 | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 26 | 12% | 1% | 200 |
10 | JOURNAL OF PSYCHOPHARMACOLOGY | 22 | 10% | 1% | 212 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diabetes mellitus and severe mental illness: mechanisms and clinical implications | 2015 | 6 | 102 | 75% |
Second-generation (atypical) antipsychotics and metabolic effects - A comprehensive literature review | 2005 | 739 | 197 | 76% |
"First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects | 2015 | 3 | 62 | 90% |
Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices | 2012 | 68 | 86 | 88% |
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia | 2009 | 194 | 30 | 87% |
A meta-analysis of the efficacy of second-generation antipsychotics | 2003 | 580 | 121 | 82% |
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) | 2009 | 218 | 108 | 74% |
Physical health monitoring of patients with schizophrenia | 2004 | 427 | 56 | 82% |
Life expectancy and cardiovascular mortality in persons with schizophrenia | 2012 | 55 | 26 | 88% |
Update on Typical and Atypical Antipsychotic Drugs | 2013 | 56 | 78 | 60% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COCHRANE IZOPHRENIA GRP | 37 | 58% | 0.2% | 42 |
2 | IZOPHRENIA PROGRAM | 23 | 22% | 0.5% | 91 |
3 | TUNKU ABDUL RAHMAN NEUROSCI | 21 | 73% | 0.1% | 16 |
4 | CHRISTIAN SARKINE AUTISM TREATMENT | 16 | 58% | 0.1% | 18 |
5 | ANTIPSYCHOT | 15 | 82% | 0.0% | 9 |
6 | MED AFFAIRS EMEA | 13 | 69% | 0.1% | 11 |
7 | ZUCKER HILLSIDE HOSP | 12 | 23% | 0.2% | 46 |
8 | VET ADM C ITOL HEALTHCARE NETWORK VISN 5 | 11 | 100% | 0.0% | 6 |
9 | UNIV PSYCHIAT | 10 | 11% | 0.5% | 85 |
10 | MENTAL HLTH NURSING INNOVAT | 10 | 34% | 0.1% | 23 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000014487 | SCHIZOPHRENIA//SCHIZOPHRENIA RESEARCH//SCHIZOPHRENIA BULLETIN |
2 | 0.0000012897 | DIMEBON//DIMEBOLIN//REMOXIPRIDE |
3 | 0.0000011896 | C 11RACLOPRIDE//FLUORINE 18//C 11FLB 457 |
4 | 0.0000011805 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
5 | 0.0000011600 | DRUG INDUCED DEPRESSION//BUZEPIDE METHIODIDE//DEPRESSIVE DISORDER CHEMICALLY INDUCED |
6 | 0.0000010957 | DOTARIZINE//DRUG INDUCED PARKINSONISM//CINNARIZINE |
7 | 0.0000009723 | ELECTROCONVULSIVE THERAPY//JOURNAL OF ECT//CONVULSIVE THERAPY |
8 | 0.0000009091 | BIPOLAR DISORDERS//JOURNAL OF AFFECTIVE DISORDERS//MANIA |
9 | 0.0000008530 | FENCAMFAMINE//N ACETYL ASPARTATE//N ACETYLASPARTATE |
10 | 0.0000006844 | HOSPITAL AND COMMUNITY PSYCHIATRY//ADMINISTRATION AND POLICY IN MENTAL HEALTH//PSYCHIATRISCHE PRAXIS |